SB

Samsara BioCapital Portfolio holdings

AUM $969M
1-Year Est. Return 134.49%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+134.49%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$497M
AUM Growth
+$496M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
50
New
Increased
Reduced
Closed

Top Buys

1
+$39.9M
2
+$24M
3
+$13M
4
TERN icon
Terns Pharmaceuticals
TERN
+$10.9M
5
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
+$8.66M

Top Sells

1
+$7.26M
2
+$6.65M
3
+$2.22M
4
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$2.17M
5
BCEL
Atreca, Inc. Class A Common Stock
BCEL
+$1.27M

Sector Composition

1 Healthcare 97.77%
2 Financials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$4.57M 0.92%
+450,000
27
$4.28M 0.86%
201,046
28
$4.23M 0.85%
399,190
29
$4.05M 0.82%
12,035
30
$3.9M 0.79%
61,050
+6,371
31
$3.52M 0.71%
100,000
32
$3.41M 0.69%
+80,000
33
$3.17M 0.64%
300,000
34
$2.93M 0.59%
300,000
35
$2.83M 0.57%
63,770
36
$2.4M 0.48%
700,421
-115,000
37
$2.03M 0.41%
10,000
38
$1.93M 0.39%
3,580
39
$1.18M 0.24%
10,795
40
$530K 0.11%
18,225
41
$434K 0.09%
25,000
-25,000
42
$155K 0.03%
1,250
43
– –
-588,961
44
– –
-294,118
45
– –
-1,224,870
46
– –
-12,966
47
– –
-67,270
48
– –
-25,000
49
– –
-165,000
50
– –
-400,000
1
2